DeepScribe’s cover photo
DeepScribe

DeepScribe

Hospitals and Health Care

San Francisco, CA 16,487 followers

Ambient AI that simplifies the delivery of complex care

About us

DeepScribe’s AI scribe automates medical documentation for doctors. Powered by the largest clinical dataset in healthcare, DeepScribe ambiently captures patient visits as they happen and then writes complete, billable documentation directly within a clinician’s electronic health record system. From small private practices to large healthcare organizations, DeepScribe is helping clinicians of all kinds reduce burnout, improve patient care, and increase revenue.

Website
https://deepscribe.ai
Industry
Hospitals and Health Care
Company size
51-200 employees
Headquarters
San Francisco, CA
Type
Privately Held
Founded
2017

Locations

Employees at DeepScribe

Updates

  • View organization page for DeepScribe

    16,487 followers

    Over the past few months, DeepScribe teams introduced clinicians to some of the most significant changes we've ever made to our ambient AI. (Get details here: https://lnkd.in/eWAvmZU5) ➡️ **Limitless note personalization** True provider customization without manual setup. Past notes are analyzed to automatically mirror each clinician’s unique style and preferences. ➡️ **Intelligent, whole-note context awareness** AI pulls relevant data into the note from disparate sources (past notes, chart data, outside records, lab results) to better interpret the current conversation. ➡️ **Higher-quality notes** Greater context, more natural-sounding documentation, with an ideal level of relevant detail for each patient; refined custom models for each specialty 📣 Of course, after making this change, we get to hear from clinicians on the spot. The feedback has been a thrill, with comments like “This is absolutely remarkable.” and “It gives me back my ability to connect with the patient on a meaningful level. It’s practicing medicine how I always wanted to.” Now on the #DeepScribe blog, insights on these advances from three leaders: Founder and CEO Matthew Ko; VP of Product, Stephanie Wu; and VP of Engineering, Andrew Beinstein. Get a peek at how DeepScribe teams took this on - and why. ➡️ An Inside Look at a Technology Leap: https://lnkd.in/eWAvmZU5 ⬅️ #AmbientAI #AIDocumentation #PhysicianWellbeing

    • DeepScribe: Andrew Beinstein, Vice President, Engineering; Matthew Ko, CEO, Co-founder; Stephanie Wu, Vice President, Product
  • What does "nirvana" look like in oncology? And what will it take to achieve it? Sounds like a blue-sky concept, right? But the pieces are in place. In our newest episode of *Beyond the Chart*, Debra Patt, MD PhD MBA talks with host Matthew Ko, #DeepScribe founder and CEO, about the path and possibilities to transform cancer care. A breast oncologist, EVP at Texas Oncology, president of the Community Oncology Alliance, and chair of the AI Task Force for the American Society of Clinical Oncology (ASCO), Dr. Patt lays out a roadmap for innovation that's anchored in workflow reality, patient connection, and the application of responsible AI. ➡️ She reminds us that we already have "the Ferraris of healthcare." 💡 We just need to create and maintain highways that let them drive impact. 🎧 Listen to the full conversation. If you like what you hear, subscribe to *Beyond the Chart* on your preferred podcast channel. We have a new episode every other week, devoted to the future of oncology. 📻 **Apple Podcasts: https://lnkd.in/edk4-WAw** 📻 **Spotify: https://lnkd.in/e9iMShwT** 📺 **YouTube: https://lnkd.in/eR8dTcWv** #AIinHealthcare #Oncology #AmbientAI #CommunityOncology #CancerCareInnovation

  • Here’s something we know from our community oncology partners: It’s incredibly rewarding to play an integral role in the community. You make a difference in the very place your patients, physicians, staff, and their families live. Being recognized for those contributions takes the community connection up a notch, and can mean the world to those involved. That’s just what happened Wednesday night to our partners at Comprehensive Cancer Centers of Nevada (CCCN), at one of the most popular venues in Greater Las Vegas: A Vegas Golden Knights NHL hockey game. 🏒 Here’s some homemade video of the moment the Knights honored CCCN and Danielle, one of their wonderful patients, with a spot on the T-Mobile Arena big screen, featuring Executive Director Lisa Santwer, MBA. (You gotta love when Danielle says “I’ll be there!” when given Knights tickets.) 😃 🙌 We honor our partners at CCCN, and the care and connection they bring to patients every day. We’re here to help them deliver an optimal care experience for the oncologists, APPs, and patients throughout Las Vegas. (By the way, Knights won, 3-2.) 😀 #communityoncology #cancercare #hockeyfightscancer

  • ❓ How do oncology leaders see the future of care? ❓ What does it mean for cancer care to be "deeply human?" That's just part of the discussion in our newest episode of **Beyond the Chart** (out today!) with special guest, Debra Patt, MD PhD MBA, breast oncologist, EVP at Texas Oncology, president of the Community Oncology Alliance, and chair of the AI Task Force for the American Society of Clinical Oncology (ASCO). (Whew!) Matthew Ko, show host and DeepScribe founder and CEO, points out that few leaders see the full intersection of patient care, policy, workflow, and technology as Dr. Patt does. Early in the conversation, Dr. Patt discusses that moment of care - indeed an overlap of onocology, technology, and humanity: ➡️ “I don’t want patients to see the back of my head because I’m typing... I want to be present with them. Touch them when they cry, hand them a tissue, walk them through education.” 🫶 Dr. Patt explains how operating at the top of her license, and thoughtfully using digital tools, lets clinicians focus on emotional presence, personalized education, and helping patients navigate a difficult journey. This episode sets the stage for the broader conversation about what “nirvana” in oncology could become. 🎧 Listen to this one-of-a-kind talk with one of the most dynamic leaders in cancer care. 🎧 📻 **Apple Podcasts: https://lnkd.in/edk4-WAw** 📻 **Spotify: https://lnkd.in/e9iMShwT** 📺 **YouTube: https://lnkd.in/eR8dTcWv** #Oncology #CancerCare #AmbientAI #AIinHealthcare #CommunityOncology #HealthcareInnovation

  • If you're not familiar with the CEO Roundtable on Cancer (CEORT), they're a nonprofit organization that brings together leaders from industry, academia, and government to accelerate the progress of eliminating cancer as a personal disease and public health problem. One of their key initiatives, Project Data Sphere, is an open, collaborative sharing of clinical trial data. We're proud that our CEO and founder Matthew Ko recently participated in the CEORT Annual Meeting in Washington, D.C., speaking in the session "Agentic AI in clinical trials: automating the enterprise, empowering the system". Matt joined (from left to right in the photo below) panel moderator Michelle Longmire M.D., CEO of Medable, Inc; Kiran Patel, VP and Global Head of Solid Tumor Clinical Development and Diagnostics for Johnson & Johnson; and James Kugler, CEO for EMD Digital of Merck KGaA, Darmstadt, Germany. As DeepScribe continues to focus on improving the care experience for oncologists and their patients, the work of CEORT and its members is nothing short of an inspiration. For more on CEORT, check out their website: https://www.ceort.org/ And check the comments for a link to Matt's interview with the organization's CEO, Dr. Sean Khozin, part of our *Beyond the Chart* podcast.

    • James Kugler on the left, watching Matthew Ko on the right speaking into a microphone.
    • A panel of four people seated in white chairs: 
Dr. Michelle Longmire, Kiran Patel, James Kugler, and Matthew Ko. James is speaking.
    • A large group of people posing for a photo outside, standing in front of two large wooden doors.
  • Earlier this week, #DeepScribe announced a milestone: capturing more than 3 million cancer care encounters a year with our ambient AI for oncology. That means more clinicians and patients having conversations of presence, connection, and meaning. ➡️ Nothing could be more important during a cancer care visit. If you've wondered about our dedication to oncology, it starts with the experiences of CEO and founder Matthew Ko while acting as care coordinator for his mom during breast cancer treatment. The commitment grows each day. From the inspiration of the oncologists we work with to the talents of our team, creating AI that understands the needs of oncology clinicians and care teams. Here's what clinicians get: ☑️ AI that integrates into pre-existing oncology workflows ☑️ AI that knows cancer care details, subtleties, medication names ☑️ Contextual awareness bringing past notes and results into the chart ☑️ Direct integration with key oncology EHRs: OncoEMR and IKnowMed ☑️ AI automated pre-charting for oncology ☑️ Coding intelligence for ICD-10, E/M, and HCC ☑️ Diagnosis intelligence directly in the EHR - recommendations before signoff ☑️ Care team collaboration That's a lot of checkmarks - thanks for checking them out. For more details, here's this week's announcement. https://lnkd.in/eT_YPwuW #oncology #ambientAI #AIDocumentation #PhysicianWellbeing #PatientExperience

    • No alternative text description for this image
  • What if the tone of a patient's voice were a fundamental part of care assessment in oncology? Dr. Sean Khozin says it can and should be. ➡️ *** Watch "Digital Biomarkers and the New Language of Cancer Care," part 1 with Dr. Khozin, on *Beyond the Chart*, hosted by DeepScribe founder and CEO Matthew Ko. || https://lnkd.in/e28vYubr *** ⬅️ As CEO of the CEO Roundtable on Cancer and Project Data Sphere, Dr. Khozin brings his expertise in oncology, technology, and even acoustics to this completely unique conversation. 🗣️ He explains how voice features like affect, cadence, and dynamic range deliver valuable clinical information that doctors may miss. Ambient AI, however, already recording patient conversations, can identify these markers. 💻 Want a quick summary of the conversation? Check out our companion blog post to the podcast: https://lnkd.in/ew_TFXyw 📺 Or watch the full episode now: https://lnkd.in/e28vYubr

    • DeepScribe | Beyond the Chart, Exploring the AI Frontier for Oncology. Hosted by Matthew Ko, CEO and Co-founder, DeepScribe 

Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer and Project Data Sphere
  • Physician burnout has been a top-of-mind topic in healthcare for years, and rightfully so. Docs' days have been overloaded with completing charts, working their inbox... stuff that's peripheral to care. But for many clinicians, the real source of burnout isn't hours spent on "paperwork", but having less presence with patients. 🩺 Dr. Diane Reidy Lagunes, Division Chief of Medical Oncology at Duke University Health System, presents that POV on the latest episode of our podcast, *Beyond the Chart*. Dr. Reidy-Lagunes and DeepScribe founder and CEO Matthew Ko discuss how ambient AI can help clinicians eliminate that lack of presence and bring more to the bedside. In addition, Dr. Reidy-Lagunes and Matt explore ways oncology-specific AI can reduce documentation burden, improve trial matching, and even turn medical jargon into patient-friendly language. 🎧 Listen or watch! Then, join the discussion in the comments. 📻 Apple Podcasts: https://lnkd.in/etjsZAby 📻 Spotify: https://lnkd.in/eUHZA68Q 📺 YouTube: https://lnkd.in/eCZaNkpP

  • In January 2021, oncologists used DeepScribe to document a patient visit 115 times. It was the modest start of something that spoke right to the origin of our company: bringing the joy of care back to medicine by focusing on the distractions that were pulling oncologists away from their patients - sometimes, literally. Now, nearly five years later, our commitment to oncology has reached a major milestone: **DeepScribe will capture more than 3 million oncology encounters a year.** ➡️ The monthly number of cancer care visits documented by DeepScribe has doubled since August. And more than quadrupled since January. ➡️ Oncology organizations that use DeepScribe see about 40% of all oncology visits. 🩺 **What does this expanded adoption mean for clinicians?** In short, greater benefits than just documentation and coding. Every oncology group on DeepScribe is positioned to benefit from greater insights throughout their workflow, from refined clinical trial matching and treatment planning to support for value-based success. **More important, what does this mean for patients?** Undivided attention from their oncologist and care team. 🥼 ➡️ And that’s what’s really behind these numbers: A true care connection for more patients. A focused, face-to-face conversation. A hand to hold during difficult news. ⬅️ It’s what drives us to keep excelling for oncologists and oncology centers across the U.S., and bringing greater value into every exam room. #oncology #ambientAI #AIDocumentation #PhysicianWellbeing #PatientCare

  • 👣 Dr. Todd Sautter is a foot and ankle surgeon often called "Dr. Todd," a sure sign of how he connects with patients at Grants Pass Podiatry in Oregon. But documenting care - what Dr. Todd calls "one of the banes of our existence" - can jeopardize the way physicians vibe with their patients. They have to either swivel between patient and computer screen, or try to remember information later, an impossible method to get all the important stuff charted. Dr. Todd has found that DeepScribe has changed all that for him. 🎉 And he sent us a video to share the details with other clinicians. Some of Dr. Todd's points about using DeepScribe ambient AI: ✅ More in-depth patient conversations ✅ Better physician-patient experience ✅ Improved documentation ✅ Learns how he likes to chart ✅ Note structure supports staff answering patient questions Many thanks to Dr. Todd Sautter for sharing his experiences with us (and you!) Check out his video and see more about our AI scribe solution at https://lnkd.in/eymtTcRW. #ambientAI #AIDocumentation #PhysicianWellbeing #PatientExperience

Similar pages

Browse jobs

Funding

DeepScribe 6 total rounds

Last Round

Series B

US$ 24.0M

See more info on crunchbase